New developments in chemotherapy of advanced breast cancer-Reference-Cited by-同舟云学术

New developments in chemotherapy of advanced breast cancer

Published:1999 Issue: Volume:10 Page:S139-S146
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Lebwohl D.E.,Canetta R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/10/suppl_6/S139/7724372/10-suppl_6-S139.pdf

Reference64 articles.

1. Phase III trial of doxorubicin (A) vs. paclitaxel (T) vs. doxorubicin + paclitaxel (A+T) as first-line therapy for metastatic breast cancer (MBC): An intergroup trial;Sledge;Proc ASCO,1997

2. Paclitaxel by 3-hour infusion in combination with dolus doxorubicin in women with untreated metastatic breast cancer High antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study;Gianni;JCO,1995

3. Phase II study of weekly intravenous recombinant humanized anti-p1 85HER2 monoclonal antibody in patients with HER2/neu- overexpressing metastatic breast cancer;Baselga;J Clin Oncol,1996

4. The intracellular histamine antagonist, N,N-diethyl-2[4- (phenylmethyl)-phenoxy] ethanamine.HCI, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study;Brandes;Breast Cancer Res Treat,1998

5. Cancer statistics, 1996;Parker;CA Cancer J Clin,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction and validation of a nomogram for predicting the prognosis of patients with lymph node-positive invasive micropapillary carcinoma of the breast: based on SEER database and external validation cohort;Frontiers in Oncology;2023-10-24

2. Targeting nucleotide metabolism: a promising approach to enhance cancer immunotherapy;Journal of Hematology & Oncology;2022-04-27

3. Trastuzumab drug delivery systems for magnetic resonance imaging detection;Design of Nanostructures for Theranostics Applications;2018

4. The application of aptamer 5TR1 in triple negative breast cancer target therapy;Journal of Cellular Biochemistry;2017-08-17

5. Estrogen Receptor Expression and Docetaxel Efficacy in Patients with Metastatic Breast Cancer: A Pooled Analysis of Four Randomized Trials;The Oncologist;2010-04-26